TENET HEALTHCARE CORP (THC)
TENET HEALTHCARE CORP (THC)
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 2,967 | 2,883 | 2,975 | |
| Accounts receivable | 2,605 | 2,565 | 2,518 | |
| Inventories of supplies, at cost | 343 | 348 | 346 | |
| Assets held for sale | 62 | 62 | 82 | |
| Other current assets | 2,379 | 1,991 | 1,889 | |
| Total current assets | 8,356 | 7,849 | 7,810 | |
| Investments and other assets | 3,809 | 2,883 | 2,939 | |
| Deferred income taxes | 84 | 84 | 72 | |
| Property and equipment, at cost, less accumulated depreciation and amortization (6,814 at march31, 2026 and 6,680 at december31, 2025) | 6,251 | 6,315 | 6,091 | |
| Goodwill | 11,387 | 11,198 | 11,158 | |
| Netbook value | NaN | 466 | 462 | |
| Other intangible assets with indefinite lives | NaN | 882 | 886 | |
| Other intangible assets, at cost, less accumulated amortization (1,378 at march31, 2026 and 1,328 at december31, 2025) | 1,316 | 1,348 | 1,348 | |
| Total assets | 31,203 | 29,677 | 29,418 | |
| Current portion of long-term debt | 81 | 79 | 85 | |
| Accounts payable | 1,339 | 1,360 | 1,356 | |
| Accrued compensation and benefits | 854 | 858 | 857 | |
| Professional and general liability reserves | 303 | 276 | 287 | |
| Accrued interest payable | 256 | 81 | 248 | |
| Liabilities held for sale | NaN | 0 | 12 | |
| Income tax payable | 236 | 0 | 28 | |
| Other current liabilities | 3,083 | 1,809 | 1,687 | |
| Total current liabilities | 6,152 | 4,463 | 4,560 | |
| Long-term debt, net of current portion | 13,128 | 13,092 | 13,102 | |
| Professional and general liability reserves | 938 | 951 | 891 | |
| Defined benefit plan obligations | 243 | 245 | 296 | |
| Deferred income taxes | 199 | 240 | 269 | |
| Other long-term liabilities | 1,693 | 1,713 | 1,600 | |
| Total liabilities | 22,353 | 20,704 | 20,718 | |
| Redeemable noncontrolling interests in equity of consolidated subsidiaries | 2,137 | 2,956 | 2,917 | |
| Common stock, 0.05 par value authorized 262,500 shares 159,129 shares issued at march31, 2026 and 158,612 shares issued at december31, 2025 | 8 | 8 | 8 | |
| Additional paid-in capital | 5,124 | 4,914 | 4,872 | |
| Accumulated other comprehensive loss | -179 | -181 | -174 | |
| Retained earnings | 5,117 | 4,415 | 4,044 | |
| Common stock in treasury, at cost, 73,005 shares at march31, 2026 and 71,660 shares at december31, 2025 | 5,256 | 4,936 | 4,736 | |
| Total shareholders equity | 4,814 | 4,220 | 4,014 | |
| Noncontrolling interests | 1,899 | 1,797 | 1,769 | |
| Total equity | 6,713 | 6,017 | 5,783 | |
| Total liabilities and equity | 31,203 | 29,677 | 29,418 | |